462
Participants
Start Date
December 19, 2019
Primary Completion Date
December 15, 2022
Study Completion Date
November 18, 2025
Pembrolizumab
intravenous (IV) infusion
Olaparib
oral tablets
Carboplatin
IV infusion
Gemcitabine
IV infusion
Koo Foundation Sun Yat-Sen Cancer Center ( Site 2300), Taipei
National Cheng Kung University Hospital ( Site 2303), Tainan City
Orszagos Onkologiai Intezet ( Site 1602), Budapest
Debreceni Egyetem Klinikai Kozpont ( Site 1600), Debrecen
Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1601), Szolnok
Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1608), Kecskemét
Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1604), Kaposvár
Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 1607), Pécs
Zala Megyei Szent Rafael Korhaz ( Site 1605), Zalaegerszeg
Zhytomyr Regional Oncology Center ( Site 1515), Zhytomyr
Memorial Sloan-Kettering Cancer Center ( Site 0156), New York
National Cancer Center ( Site 2406), Goyang-si
MacKay Memorial Hospital ( Site 2301), Taipei
Memorial Sloan-Kettering Cancer Center at Commack ( Site 0160), Commack
Seoul National University Bundang Hospital ( Site 2409), Seongnam-si
Hospital Universitario Reina Sofia ( Site 0705), Córdoba
Chernihiv Medical Center of Modern Oncology ( Site 1520), Chernihiv
Centre Francois Baclesse ( Site 1012), Caen
Ajou University Hospital ( Site 2407), Suwon
Gachon University Gil Medical Center ( Site 2408), Incheon
Virginia Oncology Associates ( Site 0164), Virginia Beach
Virginia Oncology Associates ( Site 0153), Norfolk
Virginia Oncology Associates ( Site 0163), Newport News
CHU-Jean Minjoz ( Site 1013), Besançon
Clinica Universitaria Navarra - Madrid ( Site 0700), Madrid
Gynaekologisch-onkologische Praxis Hannover ( Site 1207), Hanover
Georgia Cancer Center at Augusta University ( Site 0129), Augusta
Institut Claudius Regaud IUCT Oncopole ( Site 1001), Toulouse
Frauenklinik St. Louise ( Site 1216), Paderborn
University of Miami Sylvester CC ( Site 0146), Miami
Centre de Cancerologie du Grand Montpellier ( Site 1009), Montpellier
Universitaetsklinikum AoeR Duesseldorf ( Site 1210), Düsseldorf
China Medical University Hospital ( Site 2302), Taipei
Kyungpook National University Chilgok Hospital ( Site 2402), Daegu
Kliniken Essen-Mitte ( Site 1215), Essen
Hospital General Arnau de Vilanova de Valencia ( Site 0706), Valencia
Henry Ford Health System ( Site 0103), Detroit
Dnipropetrovsk City Multidiscipline Clinical Hosp. 4 of DRC ( Site 1502), Dnipro
CI Krivorizhskiy oncology dispensery ( Site 1504), Kryviy Rih
Gynaekologisches Zentrum-Schwerpunkt Gyn. Onkologie ( Site 1205), Bonn
Virginia Piper Cancer Institute ( Site 0157), Minneapolis
CHR-METZ-THIONVILLE - Hopital de Mercy ( Site 1007), Metz
University of Chicago ( Site 0159), Chicago
Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 1508), Kharkiv
Communal non profit enterprise Regional Clinical Oncology Center ( Site 1512), Kharkiv
SI-Zaytsev institute of general and urgent surgery-NAMS ( Site 1518), Kharkiv
Hochwaldkrankenhaus Bad Nauheim ( Site 1211), Bad Nauheim
Centre Jean Perrin ( Site 1003), Clermont-Ferrand
Sana Klinikum Offenbach Klinik fuer Gynakologie und Geburtshilfe ( Site 1206), Offenbach
Universitaetsklinikum Mannheim GmbH ( Site 1213), Mannheim
Medical center of the Limited Liability Company Yulis ( Site 1517), Zaporizhzhia
Medical Centre LLC Oncolife ( Site 1510), Zaporizhzhya
Centre Leon Berard ( Site 1018), Lyon
Mercy Clinic Oncology and Hematology ( Site 0110), Oklahoma City
Hôpital Saint-Louis ( Site 1025), Paris
MI Precarpathian Clinical Oncology Center ( Site 1506), Ivano-Frankivsk
Centre Henri Becquerel ( Site 1020), Rouen
The Center For Cancer And Blood Disorders ( Site 0151), Fort Worth
Renovatio Clinical ( Site 0117), The Woodlands
Texas Oncology-New Braunfels ( Site 0168), New Braunfels
Texas Oncology-San Antonio Northeast ( Site 0165), San Antonio
Texas Oncology-San Antonio Medical Center ( Site 0158), San Antonio
Texas Oncology - San Antonio Stone Oak ( Site 0166), San Antonio
CHU Amiens Hopital Sud ( Site 1023), Amiens
Klinik und Poliklinik fuer Frauenheilkunde und Geburtshilfe ( Site 1200), Munich
Kaohsiung Chang Gung Memorial Hospital ( Site 2304), Kaohsiung City
Institut Sainte Catherine ( Site 1026), Avignon
John Wayne Cancer Institute ( Site 0111), Santa Monica
Universitaetsklinikum Erlangen ( Site 1201), Erlangen
Pacific Cancer Care ( Site 0142), Monterey
UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138), San Francisco
Institut Gustave Roussy ( Site 1010), Villejuif
St. Joseph Heritage Healthcare ( Site 0104), Santa Rosa
YVMH dba Virginia Mason Memorial/North Star Lodge Cancer Center ( Site 0128), Yakima
Oncomedica S.A. ( Site 0606), Montería
Fundacion Valle del Lili ( Site 0602), Santiago de Cali
Hemato Oncologos S.A. ( Site 0603), Santiago de Cali
IC La Serena Research ( Site 0511), La Serena
Oncocentro ( Site 0502), Viña del Mar
Centro Investigación del Cáncer James Lind ( Site 0510), Temuco
Fundacion Arturo Lopez Perez ( Site 0500), Santiago
Pontificia Universidad Catolica de Chile ( Site 0501), Santiago
Massachusetts General Hospital ( Site 0155), Boston
Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0161), Middletown
MSKCC-Bergen ( Site 0162), Montvale
Princess Margaret Cancer Centre ( Site 0005), Toronto
CSSS de Laval- Hopital de la Cite de la Sante ( Site 0011), Laval
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0003), Montreal
Jewish General Hospital ( Site 0010), Montreal
McGill University Health Centre ( Site 0002), Montreal
Fundacion Colombiana de Cancerologia Clinica Vida ( Site 0601), Medellín
Clinica de la Costa Ltda. ( Site 0600), Barranquilla
Organizacion Clinica Bonnadona-Prevenir S.A.S. ( Site 0609), Barranquilla
Universitaetsklinikum Carl Gustav Carus ( Site 1203), Dresden
Cork University Hospital ( Site 0902), Cork
St Vincents University Hospital ( Site 0900), Dublin
Aichi Cancer Center Hospital ( Site 2202), Nagoya
Hyogo College of Medicine Hospital ( Site 2203), Nishinomiya
Fukushima Medical University Hospital ( Site 2201), Fukushima
Hiroshima City Hiroshima Citizens Hospital ( Site 2204), Hiroshima
National Hospital Organization - Osaka National Hospital - Institute For Clinical Research (Site 2200), Osaka
Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o. ( Site 1909), Pleszew
Pratia MCM Krakow ( Site 1919), Krakow
Regionalny Szpital Specjalistyczny Latawiec ( Site 1917), Swidnica
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (Site 1908), Warsaw
Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 1913), Gdynia
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1912), Gliwice
Seoul National University Hospital ( Site 2403), Seoul
Severance Hospital Yonsei University Health System ( Site 2401), Seoul
Asan Medical Center ( Site 2404), Seoul
Samsung Medical Center ( Site 2405), Seoul
Instituto Oncologico Baselga.Hospital Quiron. ( Site 0707), Barcelona
Hospital Universitari Vall d Hebron ( Site 0701), Barcelona
Hospital Clinic I Provincial de Barcelona ( Site 0702), Barcelona
Medical Centre Consilium Medical ( Site 1514), Kyiv
Medical Center Verum ( Site 1501), Kyiv
Raigmore Hospital ( Site 0915), Inverness
Blackpool Victoria Hospital ( Site 0921), Blackpool
Barts Health NHS Trust ( Site 0912), London
North West Cancer Centre ( Site 0922), Londonderry
Musgrove Park Hospital ( Site 0918), Taunton
The Christie NHS Foundation Trust ( Site 0914), Manchester
Merck Sharp & Dohme LLC
INDUSTRY